Highlights of ASH North America

Thank You for Your Attendance!

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

We extend our heartfelt thanks to all attendees for making the 2024 Highlights of ASH in North America a success.

Stay tuned for future updates!

View Program Information

Join the world's leading hematology experts at Highlights of ASH in North America, a two-day program that highlights the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical (non-malignant) hematology. ASH is pleased to conduct this year’s series as in-person meetings; there will not be a virtual meeting platform.

By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.

Through the meeting content, you will be able to:

Recap stand-out abstracts from the most recent ASH annual meeting
Discuss rapidly evolving developments in hematology and hematology-oncology with leading faculty in the field
Participate in interactive panel discussions and attend small group lunch sessions with the experts
Improve therapeutic and overall practice methods
Discover new treatments for patients

This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.

View Registration Information Get email updates

Program Schedule

The program schedule below is identical for all 2024 Highlights of ASH in North America locations.

Close All Open All

11:00 a.m.	Registration and Exhibits Open (Lunch provided)
11:45 p.m.	Welcome and Introductions
12:00 p.m.	Clonal Hematopoiesis and Myelodysplastic Syndromes
	Yazan Madanat, MD UT Southwestern	Seattle, WA, and New York, NY
	Diego Adrianzen Herrera, MD University of Vermont	Chicago, IL
	Amy E. DeZern, MD, MHS Johns Hopkins University	Washington, D.C.
12:45 p.m.	Myeloproliferative Neoplasms Including Chronic Myeloid Leukemia
	Anthony M Hunter, MD Emory University	Seattle, WA, and Washington, D.C.
	Srinivas Tantravahi, MD University of Utah	Chicago, IL
	Natasha Szuber, MD, MSc Université de Montréal	New York, NY
1:30 p.m.	Chronic Lymphocytic Leukemia
	Brian Hill, MD Cleveland Clinic	Seattle, WA
	Jacqueline Barrientos, MD, MS Mount Sinai Medical Center	Chicago, IL, and New York, NY
	Adam Kittai, MD Ohio State University	Washington, D.C.
2:15 p.m.	Panel Discussion
2:45 p.m.	Coffee Break and Exhibits Open
3:00 p.m.	Hemoglobinopathies
	Kevin Kuo, MD, MSc, FRCPC University Health Network	Seattle, WA, and Chicago, IL
	Seethal A. Jacob, MD, MS, FAAP Indiana University	Washington, D.C., and New York, NY
3:45 p.m.	Inherited Bleeding Disorders
	Angela Weyand, MD University of Michigan	Seattle, WA
	Kristen Sanfilippo, MD Washington University in St. Louis	Chicago, IL, and New York, NY
	Tyler Buckner, MD, MSc University of Colorado Denver	Washington, D.C.
4:30 p.m.	Diagnosis, Management, and Treatment of VTE (Venous Thromboembolism)
	Neil Zakai, MD University of Vermont	Seattle, WA
	Karlyn Martin, MD University of Vermont	Chicago, IL
	Jean Connors, MD Brigham and Women's Hospital/Harvard Medical School	New York, NY
	Radhika Gangaraju MD University of Alabama at Birmingham	Washington, D.C.
5:15 p.m.	Panel Discussion
5:45 p.m.	Program Adjourns for the day
5:45 p.m.	CME Satellite Symposia: "Reviving the BTK Target in MCL: Recalibrating the Treatment Sequence with Non-Covalent BTK Inhibitors in R/R Disease" Fairmont Chicago - Crystal Ballroom (3rd Floor), Chicago, IL Join Drs. Nirav Shah and Krish Patel for this dinner symposium!

7:00 a.m.	Registration and Exhibits Open (Breakfast provided)
7:45 a.m.	Welcome, Introductions, and Announcements
8:00 a.m.	Transfusion Medicine: Blood Banking and Pheresis
	Nadine Shehata, MD, MSc, FRCPC Mount Sinai Medical Center	Seattle, WA, and Washington, D.C.
	Stella Chou, MD The Children's Hospital of Philadelphia	Chicago, IL
	Patricia A. Shi, MD New York Blood Center	New York, NY
8:45 a.m.	Autoimmunity and Complement Disorders
	Yazan Abou-Ismail, MD University of Utah	Seattle, WA, and New York, NY
	Shruti Chaturvedi, MBBS Johns Hopkins University	Chicago, IL
	Allyson Pishko, MD University of Pennsylvania	Washington, D.C.
9:30 a.m.	Nosocomial Hematological Complications
	Lana Castellucci, MD, MSc University of Ottawa	Seattle, WA
	Donald M. Arnold, MD McMaster University	Chicago, IL
	Ang Li, MD, MS Baylor College of Medicine	Washington, D.C.
	Adam Cuker, MD University of Pennsylvania	New York, NY
10:15 a.m.	Panel Discussion
10:45 a.m.	Coffee Break and Exhibits Open
11:00 a.m.	Myeloma & Plasma Cell Dyscrasia
	Rajshekhar Chakraborty, MD Columbia University	Seattle, WA
	Surbhi Sidana, MD Stanford University	Chicago, IL
	Jonathan L. Kaufman, MD Emory University	Washington, D.C., and New York, NY
11:45 a.m.	Lymphoma
	Elizabeth Budde, MD, PhD City of Hope Hematology & HCT	Seattle, WA, and Chicago, IL
	Oreofe Odejide, MD, MPH Dana-Farber Cancer Institute	New York, NY
	Adam Kittai, MD Ohio State University	Washington, D.C.
12:30 p.m.	Panel Discussion
1:00 p.m.	Lunch with the Experts (All Speakers and Attendees)
2:15 p.m.	Hematopoietic Stem Cell Transplantation
	Shernan Holtan, MD University of Minnesota	Seattle, WA
	Betty Hamilton, MD Cleveland Clinic	Chicago, IL, and New York, NY
	John Magenau, MD University of Michigan	Washington, D.C.
3:00 p.m.	Acute Lymphoblastic Leukemia
	John Molina, MD, MEd Cleveland Clinic	Seattle, WA
	Anand Patel, MD University of Chicago	Chicago, IL, and New York, NY
	Ryan Cassaday, MD Fred Hutchinson Cancer Center	Washington, D.C.
3:45 p.m.	Acute Myeloid Leukemia
	Pamela Egan, MD Maine Health Cancer Care/ Tufts University School of Medicine	Seattle, WA
	Yazan Madanat, MD UT Southwestern	New York, NY
	Justin Watts, MD University of Miami	Chicago, IL
	Anthony M. Hunter, MD Emory University	Washington, D.C.
4:30 p.m.	Panel Discussion
5:00 p.m.	Closing Remarks and Adjournment

View Faculty Disclosure Information

Highlights of ASH Steering Subcommittee

Neil Zakai, MD, MSc, Chair, University of Vermont
Tyler Buckner, MD, MSc, University of Colorado Denver
Jean Connors, MD, Brigham and Women’s Hospital/ Harvard Medical School
Amy DeZern, MD, Johns Hopkins University
Pamela Egan, MD, Rhode Island Hospital
Betty K. Hamilton, MD, Cleveland Clinic
Jonathan L. Kaufman, MD, Emory University
Eric Tse, PhD, MBBS, Hong Kong University
Alison Walker, MD, Moffitt Cancer Center

Hotel Information

ASH is pleased to offer discounted room rates at each Highlights of ASH hotel for all meeting attendees. Please be sure to note the reservation deadline date for the hotel you select.

Learn More

The American Society of Hematology would like to acknowledge the following companies for the educational grants provided in support of the 2024 Highlights of ASH ® in North America.

AstraZeneca
Incyte Corporation
Lilly USA, LLC
Novartis Pharmaceuticals